Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2024

Nov 20, 2024

30561_dirs_2024-11-19_e0a46237-9fd8-45fd-879c-0973fc506f2c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2024-11-15

Reporting Person: Peterson Amy C. (EVP Prod Dev & Med Aff & CMO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-11-15 Common Stock F 27224 $35.05 Disposed 294897 Direct

Footnotes

F1: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units ("RSUs") awarded August 24, 2023.

F2: Includes 262,121 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs. Each RSU is the economic equivalent of one share of Common Stock.